Dr. Daniel Schrider Promoted to Associate Professor with Tenure
June 28, 2023
Dan Schrider, PhD has been promoted to Associate Professor with tenure in the Department of Genetics, effective July 1, 2023.
News
Dr. Hyejung Won Promoted to Associate Professor with Tenure
June 28, 2023
Hyejung Won, PhD has been promoted to Associate Professor with tenure in the Department of Genetics, effective July 1, 2023.
Department of Genetics Publications for June 4th – 17th, 2023
June 19, 2023
Department of Genetics faculty, postdocs, students and collaborators published 10 papers during June 4th - 17th, 2023.
Department of Genetics Publications for May 21st – June 3rd, 2023
June 4, 2023
Department of Genetics faculty, postdocs, students and collaborators published 15 papers during May 21st – June 3rd, 2023.
Dr. Hector Franco Promoted to Associate Professor with Tenure
May 31, 2023
Hector Franco, PhD has been promoted to Associate Professor with tenure in the Department of Genetics, effective June 1, 2023.
Volleying Research and Life
May 26, 2023
From pickleball to LEGO, Carolina researchers engage in a variety of hobbies to escape stressors that come with a career in academia.
Department of Genetics Publications for May 7th – 20th, 2023
May 22, 2023
Department of Genetics faculty, postdocs, students and collaborators published 9 papers during May 7th – 20th, 2023.
Genetics Faculty Featured at UNC Lineberger’s 46th Annual Scientific Symposium
May 11, 2023
Leading investigators offer ‘highly scientific, but patient-focused’ talks on women’s cancers at symposium
Department of Genetics Publications for April 23rd – May 6th, 2023
May 7, 2023
Department of Genetics faculty, postdocs, students and collaborators published 11 papers during April 23rd – May 6th, 2023.
Dr. Mark Heise Inks Deal with Moderna Therapeutics to Develop Improved Models to Study Vaccine Safety and Immunogenicity
May 3, 2023
Mark Heise, PhD (Professor, Genetics and Microbiology & Immunology) was awarded a scientific research agreement from Moderna Therapeutics to utilize the Collaborative Cross (CC) to improve models to study the safety and immunogenicity of vaccines.